RET and medullary thyroid gland carcinoma: In addition, and in keeping with other reports [18,34], we demonstrated the presence of a germline RET mutation in more than 6% of apparently sporadic MTC patients, thus confirming the important role of RET genetic screening for the identification of unsuspected MEN2 families [18].